Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
---|
DVA - DaVita HealthCare Partners Inc | SELL | -391 @ USD 140.95 | USD -55,111 | The ETF sold 391 shares of DVA on 2025-06-24. The shares were previously bought for an average price of USD 152.128. The DaVita HealthCare Partners Inc shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 4,371 The average price that the ETF previously sold DVA share for is USD 148.372 which is higher than the selling price of USD 140.95 on 2025-06-24. |
CRL - Creightons Plc | SELL | -459 @ USD 148.4 | USD -68,116 | The ETF sold 459 shares of CRL on 2025-06-24. The shares were previously bought for an average price of USD 166.082. The Creightons Plc shares were sold for -10.6% lower than average price of previous purchases. This resulted in an overall loss of USD 8,116 The average price that the ETF previously sold CRL share for is USD 177.544 which is higher than the selling price of USD 148.4 on 2025-06-24. |
TECH - Bio-Techne Corp | SELL | -1,479 @ USD 50 | USD -73,950 | The ETF sold 1479 shares of TECH on 2025-06-24. The shares were previously bought for an average price of USD 63.0518. The Bio-Techne Corp shares were sold for -20.7% lower than average price of previous purchases. This resulted in an overall loss of USD 19,304 The average price that the ETF previously sold TECH share for is USD 69.0215 which is higher than the selling price of USD 50 on 2025-06-24. |
MRNA - Moderna Inc | SELL | -3,128 @ USD 26.8 | USD -83,830 | The ETF sold 3128 shares of MRNA on 2025-06-24. The shares were previously bought for an average price of USD 34.154. The Moderna Inc shares were sold for -21.5% lower than average price of previous purchases. This resulted in an overall loss of USD 23,003 The average price that the ETF previously sold MRNA share for is USD 40.4777 which is higher than the selling price of USD 26.8 on 2025-06-24. |
HSIC - Henry Schein Inc | SELL | -1,173 @ USD 72.68 | USD -85,254 | The ETF sold 1173 shares of HSIC on 2025-06-24. The shares were previously bought for an average price of USD 72.5124. The Henry Schein Inc shares were sold for 0.2% higher than average price of previous purchases. This sale made a profit of USD 197 The average price that the ETF previously sold HSIC share for is USD 71.1228 so the ETF has sold 1173 shares on 2025-06-24 at a higher price than the previous selling average. |
UHS - Universal Health Services Inc | SELL | -527 @ USD 175.2 | USD -92,330 | The ETF sold 527 shares of UHS on 2025-06-24. The shares were previously bought for an average price of USD 186.925. The Universal Health Services Inc shares were sold for -6.3% lower than average price of previous purchases. This resulted in an overall loss of USD 6,179 The average price that the ETF previously sold UHS share for is USD 191.618 which is higher than the selling price of USD 175.2 on 2025-06-24. |
SOLV - Solventum Corp. | SELL | -1,309 @ USD 74.98 | USD -98,149 | The ETF sold 1309 shares of SOLV on 2025-06-24. The shares were previously bought for an average price of USD 73.8832. The Solventum Corp. shares were sold for 1.5% higher than average price of previous purchases. This sale made a profit of USD 1,436 The average price that the ETF previously sold SOLV share for is USD 70.5093 so the ETF has sold 1309 shares on 2025-06-24 at a higher price than the previous selling average. |
VTRS - Viatris Inc | SELL | -11,373 @ USD 8.95 | USD -101,788 | The ETF sold 11373 shares of VTRS on 2025-06-24. The shares were previously bought for an average price of USD 10.2318. The Viatris Inc shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 14,578 The average price that the ETF previously sold VTRS share for is USD 11.8738 which is higher than the selling price of USD 8.95 on 2025-06-24. |
INCY - Incyte Corporation | SELL | -1,513 @ USD 69.01 | USD -104,412 | The ETF sold 1513 shares of INCY on 2025-06-24. The shares were previously bought for an average price of USD 68.9748. The Incyte Corporation shares were sold for 0.1% higher than average price of previous purchases. This sale made a profit of USD 53 The average price that the ETF previously sold INCY share for is USD 72.1288 which is higher than the selling price of USD 69.01 on 2025-06-24. |
RVTY - Revvity Inc. | SELL | -1,105 @ USD 96.39 | USD -106,511 | The ETF sold 1105 shares of RVTY on 2025-06-24. The shares were previously bought for an average price of USD 110.103. The Revvity Inc. shares were sold for -12.5% lower than average price of previous purchases. This resulted in an overall loss of USD 15,153 The average price that the ETF previously sold RVTY share for is USD 110.341 which is higher than the selling price of USD 96.39 on 2025-06-24. |
ALGN - Align Technology Inc | SELL | -629 @ USD 186.58 | USD -117,359 | The ETF sold 629 shares of ALGN on 2025-06-24. The shares were previously bought for an average price of USD 186.986. The Align Technology Inc shares were sold for -0.2% lower than average price of previous purchases. This resulted in an overall loss of USD 255 The average price that the ETF previously sold ALGN share for is USD 208.135 which is higher than the selling price of USD 186.58 on 2025-06-24. |
COO - The Cooper Companies, Inc. Common Stock | SELL | -1,904 @ USD 70.93 | USD -135,051 | The ETF sold 1904 shares of COO on 2025-06-24. The shares were previously bought for an average price of USD 86.955. The The Cooper Companies, Inc. Common Stock shares were sold for -18.4% lower than average price of previous purchases. This resulted in an overall loss of USD 30,512 The average price that the ETF previously sold COO share for is USD 94.2578 which is higher than the selling price of USD 70.93 on 2025-06-24. |
HOLX - Hologic Inc | SELL | -2,108 @ USD 64.83 | USD -136,662 | The ETF sold 2108 shares of HOLX on 2025-06-24. The shares were previously bought for an average price of USD 66.597. The Hologic Inc shares were sold for -2.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,725 The average price that the ETF previously sold HOLX share for is USD 71.5267 which is higher than the selling price of USD 64.83 on 2025-06-24. |
WST - West Pharmaceutical Services Inc | SELL | -663 @ USD 222.68 | USD -147,637 | The ETF sold 663 shares of WST on 2025-06-24. The shares were previously bought for an average price of USD 251.507. The West Pharmaceutical Services Inc shares were sold for -11.5% lower than average price of previous purchases. This resulted in an overall loss of USD 19,112 The average price that the ETF previously sold WST share for is USD 297.741 which is higher than the selling price of USD 222.68 on 2025-06-24. |
BAX - Baxter International Inc | SELL | -4,879 @ USD 30.59 | USD -149,249 | The ETF sold 4879 shares of BAX on 2025-06-24. The shares were previously bought for an average price of USD 32.4352. The Baxter International Inc shares were sold for -5.7% lower than average price of previous purchases. This resulted in an overall loss of USD 9,003 The average price that the ETF previously sold BAX share for is USD 32.3277 which is higher than the selling price of USD 30.59 on 2025-06-24. |
MOH - MOH | SELL | -510 @ USD 294.51 | USD -150,200 | The ETF sold 510 shares of MOH on 2025-06-24. The shares were previously bought for an average price of USD 307.226. The MOH shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 6,485 The average price that the ETF previously sold MOH share for is USD 306.275 which is higher than the selling price of USD 294.51 on 2025-06-24. |
MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -510 @ USD 294.51 | USD -150,200 | The ETF sold 510 shares of MOH on 2025-06-24. The shares were previously bought for an average price of USD 307.226. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -4.1% lower than average price of previous purchases. This resulted in an overall loss of USD 6,485 The average price that the ETF previously sold MOH share for is USD 306.275 which is higher than the selling price of USD 294.51 on 2025-06-24. |
ZBH - Zimmer Biomet Holdings Inc | SELL | -1,853 @ USD 92.34 | USD -171,106 | The ETF sold 1853 shares of ZBH on 2025-06-24. The shares were previously bought for an average price of USD 104.991. The Zimmer Biomet Holdings Inc shares were sold for -12.0% lower than average price of previous purchases. This resulted in an overall loss of USD 23,442 The average price that the ETF previously sold ZBH share for is USD 106.314 which is higher than the selling price of USD 92.34 on 2025-06-24. |
BIIB - Biogen Inc | SELL | -1,377 @ USD 126.31 | USD -173,929 | The ETF sold 1377 shares of BIIB on 2025-06-24. The shares were previously bought for an average price of USD 141.087. The Biogen Inc shares were sold for -10.5% lower than average price of previous purchases. This resulted in an overall loss of USD 20,348 The average price that the ETF previously sold BIIB share for is USD 155.821 which is higher than the selling price of USD 126.31 on 2025-06-24. |
DGX - Quest Diagnostics Incorporated | SELL | -1,054 @ USD 179.9 | USD -189,615 | The ETF sold 1054 shares of DGX on 2025-06-24. The shares were previously bought for an average price of USD 168.37. The Quest Diagnostics Incorporated shares were sold for 6.8% higher than average price of previous purchases. This sale made a profit of USD 12,153 The average price that the ETF previously sold DGX share for is USD 160.999 so the ETF has sold 1054 shares on 2025-06-24 at a higher price than the previous selling average. |
WAT - Waters Corporation | SELL | -561 @ USD 346.8 | USD -194,555 | The ETF sold 561 shares of WAT on 2025-06-24. The shares were previously bought for an average price of USD 362.912. The Waters Corporation shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 9,039 The average price that the ETF previously sold WAT share for is USD 370.741 which is higher than the selling price of USD 346.8 on 2025-06-24. |
WAT - MULETFWATIMETFP | SELL | -561 @ USD 346.8 | USD -194,555 | The ETF sold 561 shares of WAT on 2025-06-24. The shares were previously bought for an average price of USD 362.912. The MULETFWATIMETFP shares were sold for -4.4% lower than average price of previous purchases. This resulted in an overall loss of USD 9,039 The average price that the ETF previously sold WAT share for is USD 370.741 which is higher than the selling price of USD 346.8 on 2025-06-24. |
PODD - Insulet Corporation | SELL | -646 @ USD 310.9 | USD -200,841 | The ETF sold 646 shares of PODD on 2025-06-24. The shares were previously bought for an average price of USD 277.177. The Insulet Corporation shares were sold for 12.2% higher than average price of previous purchases. This sale made a profit of USD 21,785 The average price that the ETF previously sold PODD share for is USD 265.956 so the ETF has sold 646 shares on 2025-06-24 at a higher price than the previous selling average. |
LH - Laboratory Corporation of America Holdings | SELL | -782 @ USD 262.53 | USD -205,298 | The ETF sold 782 shares of LH on 2025-06-24. The shares were previously bought for an average price of USD 246.011. The Laboratory Corporation of America Holdings shares were sold for 6.7% higher than average price of previous purchases. This sale made a profit of USD 12,918 The average price that the ETF previously sold LH share for is USD 237.307 so the ETF has sold 782 shares on 2025-06-24 at a higher price than the previous selling average. |
MTD - Mettler-Toledo International Inc | SELL | -187 @ USD 1185.18 | USD -221,629 | The ETF sold 187 shares of MTD on 2025-06-24. The shares were previously bought for an average price of USD 1228.41. The Mettler-Toledo International Inc shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 8,084 The average price that the ETF previously sold MTD share for is USD 1233.84 which is higher than the selling price of USD 1185.18 on 2025-06-24. |
MTD - AMUNDI EUR GOV 710 | SELL | -187 @ USD 1185.18 | USD -221,629 | The ETF sold 187 shares of MTD on 2025-06-24. The shares were previously bought for an average price of USD 1228.41. The AMUNDI EUR GOV 710 shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 8,084 The average price that the ETF previously sold MTD share for is USD 1233.84 which is higher than the selling price of USD 1185.18 on 2025-06-24. |
STE - STERIS plc | SELL | -935 @ USD 239.59 | USD -224,017 | The ETF sold 935 shares of STE on 2025-06-24. The shares were previously bought for an average price of USD 223.826. The STERIS plc shares were sold for 7.0% higher than average price of previous purchases. This sale made a profit of USD 14,739 The average price that the ETF previously sold STE share for is USD 217.529 so the ETF has sold 935 shares on 2025-06-24 at a higher price than the previous selling average. |
IQV - IQVIA Holdings Inc | SELL | -1,530 @ USD 158.58 | USD -242,627 | The ETF sold 1530 shares of IQV on 2025-06-24. The shares were previously bought for an average price of USD 186.657. The IQVIA Holdings Inc shares were sold for -15.0% lower than average price of previous purchases. This resulted in an overall loss of USD 42,958 The average price that the ETF previously sold IQV share for is USD 191.794 which is higher than the selling price of USD 158.58 on 2025-06-24. |
CNC - Concurrent Technologies Plc | SELL | -4,692 @ USD 54.05 | USD -253,603 | The ETF sold 4692 shares of CNC on 2025-06-24. The shares were previously bought for an average price of USD 59.4539. The Concurrent Technologies Plc shares were sold for -9.1% lower than average price of previous purchases. This resulted in an overall loss of USD 25,355 The average price that the ETF previously sold CNC share for is USD 59.8539 which is higher than the selling price of USD 54.05 on 2025-06-24. |
HUM - Hummingbird Resources PLC | SELL | -1,139 @ USD 238.79 | USD -271,982 | The ETF sold 1139 shares of HUM on 2025-06-24. The shares were previously bought for an average price of USD 263.78. The Hummingbird Resources PLC shares were sold for -9.5% lower than average price of previous purchases. This resulted in an overall loss of USD 28,464 The average price that the ETF previously sold HUM share for is USD 274.377 which is higher than the selling price of USD 238.79 on 2025-06-24. |
HUM - Humana Inc | SELL | -1,139 @ USD 238.79 | USD -271,982 | The ETF sold 1139 shares of HUM on 2025-06-24. The shares were previously bought for an average price of USD 263.78. The Humana Inc shares were sold for -9.5% lower than average price of previous purchases. This resulted in an overall loss of USD 28,464 The average price that the ETF previously sold HUM share for is USD 274.377 which is higher than the selling price of USD 238.79 on 2025-06-24. |
GEHC - GE HealthCare Technologies Inc. | SELL | -4,335 @ USD 71.98 | USD -312,033 | The ETF sold 4335 shares of GEHC on 2025-06-24. The shares were previously bought for an average price of USD 82.1201. The GE HealthCare Technologies Inc. shares were sold for -12.3% lower than average price of previous purchases. This resulted in an overall loss of USD 43,957 The average price that the ETF previously sold GEHC share for is USD 80.576 which is higher than the selling price of USD 71.98 on 2025-06-24. |
A - Agilent Technologies Inc | SELL | -2,703 @ USD 117.64 | USD -317,981 | The ETF sold 2703 shares of A on 2025-06-24. The shares were previously bought for an average price of USD 126.47. The Agilent Technologies Inc shares were sold for -7.0% lower than average price of previous purchases. This resulted in an overall loss of USD 23,867 The average price that the ETF previously sold A share for is USD 131.436 which is higher than the selling price of USD 117.64 on 2025-06-24. |
DXCM - DexCom Inc | SELL | -3,689 @ USD 87.57 | USD -323,046 | The ETF sold 3689 shares of DXCM on 2025-06-24. The shares were previously bought for an average price of USD 78.3127. The DexCom Inc shares were sold for 11.8% higher than average price of previous purchases. This sale made a profit of USD 34,150 The average price that the ETF previously sold DXCM share for is USD 76.195 so the ETF has sold 3689 shares on 2025-06-24 at a higher price than the previous selling average. |
RMD - ResMed Inc | SELL | -1,394 @ USD 255.91 | USD -356,739 | The ETF sold 1394 shares of RMD on 2025-06-24. The shares were previously bought for an average price of USD 237.245. The ResMed Inc shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of USD 26,019 The average price that the ETF previously sold RMD share for is USD 240.721 so the ETF has sold 1394 shares on 2025-06-24 at a higher price than the previous selling average. |
CAH - Cardinal Health Inc | SELL | -2,244 @ USD 164.21 | USD -368,487 | The ETF sold 2244 shares of CAH on 2025-06-24. The shares were previously bought for an average price of USD 132.507. The Cardinal Health Inc shares were sold for 23.9% higher than average price of previous purchases. This sale made a profit of USD 71,142 The average price that the ETF previously sold CAH share for is USD 126.751 so the ETF has sold 2244 shares on 2025-06-24 at a higher price than the previous selling average. |
IDXX - IDEXX Laboratories Inc | SELL | -748 @ USD 530.5 | USD -396,814 | The ETF sold 748 shares of IDXX on 2025-06-24. The shares were previously bought for an average price of USD 450.814. The IDEXX Laboratories Inc shares were sold for 17.7% higher than average price of previous purchases. This sale made a profit of USD 59,605 The average price that the ETF previously sold IDXX share for is USD 434.599 so the ETF has sold 748 shares on 2025-06-24 at a higher price than the previous selling average. |
EW - Edwards Lifesciences Corp | SELL | -5,542 @ USD 75.85 | USD -420,361 | The ETF sold 5542 shares of EW on 2025-06-24. The shares were previously bought for an average price of USD 71.5297. The Edwards Lifesciences Corp shares were sold for 6.0% higher than average price of previous purchases. This sale made a profit of USD 23,943 The average price that the ETF previously sold EW share for is USD 70.7272 so the ETF has sold 5542 shares on 2025-06-24 at a higher price than the previous selling average. |
BDX - Becton Dickinson and Company | SELL | -2,703 @ USD 171.57 | USD -463,754 | The ETF sold 2703 shares of BDX on 2025-06-24. The shares were previously bought for an average price of USD 219.469. The Becton Dickinson and Company shares were sold for -21.8% lower than average price of previous purchases. This resulted in an overall loss of USD 129,471 The average price that the ETF previously sold BDX share for is USD 219.539 which is higher than the selling price of USD 171.57 on 2025-06-24. |
COR - Cencora Inc. | SELL | -1,615 @ USD 294.12 | USD -475,004 | The ETF sold 1615 shares of COR on 2025-06-24. The shares were previously bought for an average price of USD 261.514. The Cencora Inc. shares were sold for 12.5% higher than average price of previous purchases. This sale made a profit of USD 52,659 The average price that the ETF previously sold COR share for is USD 249.176 so the ETF has sold 1615 shares on 2025-06-24 at a higher price than the previous selling average. |
REGN - Regeneron Pharmaceuticals Inc | SELL | -986 @ USD 522.27 | USD -514,958 | The ETF sold 986 shares of REGN on 2025-06-24. The shares were previously bought for an average price of USD 680.886. The Regeneron Pharmaceuticals Inc shares were sold for -23.3% lower than average price of previous purchases. This resulted in an overall loss of USD 156,395 The average price that the ETF previously sold REGN share for is USD 725.573 which is higher than the selling price of USD 522.27 on 2025-06-24. |
HCA - HCA Holdings Inc | SELL | -1,632 @ USD 379.02 | USD -618,561 | The ETF sold 1632 shares of HCA on 2025-06-24. The shares were previously bought for an average price of USD 342.603. The HCA Holdings Inc shares were sold for 10.6% higher than average price of previous purchases. This sale made a profit of USD 59,433 The average price that the ETF previously sold HCA share for is USD 334.468 so the ETF has sold 1632 shares on 2025-06-24 at a higher price than the previous selling average. |
ZTS - Zoetis Inc | SELL | -4,199 @ USD 157.77 | USD -662,476 | The ETF sold 4199 shares of ZTS on 2025-06-24. The shares were previously bought for an average price of USD 166.437. The Zoetis Inc shares were sold for -5.2% lower than average price of previous purchases. This resulted in an overall loss of USD 36,393 The average price that the ETF previously sold ZTS share for is USD 170.879 which is higher than the selling price of USD 157.77 on 2025-06-24. |
CVS - CVS Health Corp | SELL | -11,520 @ USD 67.58 | USD -778,522 | The ETF sold 11520 shares of CVS on 2025-06-24. The shares were previously bought for an average price of USD 63.5284. The CVS Health Corp shares were sold for 6.4% higher than average price of previous purchases. This sale made a profit of USD 46,674 The average price that the ETF previously sold CVS share for is USD 55.848 so the ETF has sold 11520 shares on 2025-06-24 at a higher price than the previous selling average. |
CI - Cigna Corp | SELL | -2,516 @ USD 316.83 | USD -797,144 | The ETF sold 2516 shares of CI on 2025-06-24. The shares were previously bought for an average price of USD 316.24. The Cigna Corp shares were sold for 0.2% higher than average price of previous purchases. This sale made a profit of USD 1,484 The average price that the ETF previously sold CI share for is USD 313.018 so the ETF has sold 2516 shares on 2025-06-24 at a higher price than the previous selling average. |
ELV - Elevance Health Inc | SELL | -2,142 @ USD 376.42 | USD -806,292 | The ETF sold 2142 shares of ELV on 2025-06-24. The shares were previously bought for an average price of USD 406.141. The Elevance Health Inc shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 63,662 The average price that the ETF previously sold ELV share for is USD 399.15 which is higher than the selling price of USD 376.42 on 2025-06-24. |
ELV - Elevance Health Inc | SELL | -2,142 @ USD 376.42 | USD -806,292 | The ETF sold 2142 shares of ELV on 2025-06-24. The shares were previously bought for an average price of USD 406.141. The Elevance Health Inc shares were sold for -7.3% lower than average price of previous purchases. This resulted in an overall loss of USD 63,662 The average price that the ETF previously sold ELV share for is USD 399.15 which is higher than the selling price of USD 376.42 on 2025-06-24. |
MCK - McKesson Corporation | SELL | -1,173 @ USD 720.82 | USD -845,522 | The ETF sold 1173 shares of MCK on 2025-06-24. The shares were previously bought for an average price of USD 638.392. The McKesson Corporation shares were sold for 12.9% higher than average price of previous purchases. This sale made a profit of USD 96,688 The average price that the ETF previously sold MCK share for is USD 609.337 so the ETF has sold 1173 shares on 2025-06-24 at a higher price than the previous selling average. |
BMY - Bloomsbury Publishing Plc | SELL | -19,295 @ USD 47.03 | USD -907,444 | The ETF sold 19295 shares of BMY on 2025-06-24. The shares were previously bought for an average price of USD 55.47. The Bloomsbury Publishing Plc shares were sold for -15.2% lower than average price of previous purchases. This resulted in an overall loss of USD 162,850 The average price that the ETF previously sold BMY share for is USD 55.9168 which is higher than the selling price of USD 47.03 on 2025-06-24. |
MDT - Medtronic PLC | SELL | -12,155 @ USD 86.08 | USD -1,046,302 | The ETF sold 12155 shares of MDT on 2025-06-24. The shares were previously bought for an average price of USD 88.3296. The Medtronic PLC shares were sold for -2.5% lower than average price of previous purchases. This resulted in an overall loss of USD 27,344 The average price that the ETF previously sold MDT share for is USD 85.4871 so the ETF has sold 12155 shares on 2025-06-24 at a higher price than the previous selling average. |
VRTX - Vertex Pharmaceuticals Inc | SELL | -2,414 @ USD 450.27 | USD -1,086,952 | The ETF sold 2414 shares of VRTX on 2025-06-24. The shares were previously bought for an average price of USD 472.249. The Vertex Pharmaceuticals Inc shares were sold for -4.7% lower than average price of previous purchases. This resulted in an overall loss of USD 53,057 The average price that the ETF previously sold VRTX share for is USD 462.562 which is higher than the selling price of USD 450.27 on 2025-06-24. |
DHR - Danaher Corporation | SELL | -6,018 @ USD 197.47 | USD -1,188,374 | The ETF sold 6018 shares of DHR on 2025-06-24. The shares were previously bought for an average price of USD 213.928. The Danaher Corporation shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 99,044 The average price that the ETF previously sold DHR share for is USD 228.984 which is higher than the selling price of USD 197.47 on 2025-06-24. |
DHR - Danaher Corporation | SELL | -6,018 @ USD 197.47 | USD -1,188,374 | The ETF sold 6018 shares of DHR on 2025-06-24. The shares were previously bought for an average price of USD 213.928. The Danaher Corporation shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 99,044 The average price that the ETF previously sold DHR share for is USD 228.984 which is higher than the selling price of USD 197.47 on 2025-06-24. |
SYK - Stryker Corporation | SELL | -3,247 @ USD 386.46 | USD -1,254,836 | The ETF sold 3247 shares of SYK on 2025-06-24. The shares were previously bought for an average price of USD 378.816. The Stryker Corporation shares were sold for 2.0% higher than average price of previous purchases. This sale made a profit of USD 24,820 The average price that the ETF previously sold SYK share for is USD 375.436 so the ETF has sold 3247 shares on 2025-06-24 at a higher price than the previous selling average. |
GILD - Guild Esports Plc | SELL | -11,781 @ USD 107.2 | USD -1,262,923 | The ETF sold 11781 shares of GILD on 2025-06-24. The shares were previously bought for an average price of USD 103.745. The Guild Esports Plc shares were sold for 3.3% higher than average price of previous purchases. This sale made a profit of USD 40,703 The average price that the ETF previously sold GILD share for is USD 95.473 so the ETF has sold 11781 shares on 2025-06-24 at a higher price than the previous selling average. |
PFE - Pfizer Inc | SELL | -53,907 @ USD 24.31 | USD -1,310,479 | The ETF sold 53907 shares of PFE on 2025-06-24. The shares were previously bought for an average price of USD 25.4735. The Pfizer Inc shares were sold for -4.6% lower than average price of previous purchases. This resulted in an overall loss of USD 62,721 The average price that the ETF previously sold PFE share for is USD 25.784 which is higher than the selling price of USD 24.31 on 2025-06-24. |
AMGN - Amgen Inc | SELL | -5,083 @ USD 277.49 | USD -1,410,482 | The ETF sold 5083 shares of AMGN on 2025-06-24. The shares were previously bought for an average price of USD 300.794. The Amgen Inc shares were sold for -7.7% lower than average price of previous purchases. This resulted in an overall loss of USD 118,454 The average price that the ETF previously sold AMGN share for is USD 288.959 which is higher than the selling price of USD 277.49 on 2025-06-24. |
TMO - Time Out Group plc | SELL | -3,570 @ USD 404.37 | USD -1,443,601 | The ETF sold 3570 shares of TMO on 2025-06-24. The shares were previously bought for an average price of USD 505.609. The Time Out Group plc shares were sold for -20.0% lower than average price of previous purchases. This resulted in an overall loss of USD 361,423 The average price that the ETF previously sold TMO share for is USD 509.86 which is higher than the selling price of USD 404.37 on 2025-06-24. |
BSX - Boston Scientific Corporation | SELL | -14,025 @ USD 104.12 | USD -1,460,283 | The ETF sold 14025 shares of BSX on 2025-06-24. The shares were previously bought for an average price of USD 99.2287. The Boston Scientific Corporation shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of USD 68,600 The average price that the ETF previously sold BSX share for is USD 91.2952 so the ETF has sold 14025 shares on 2025-06-24 at a higher price than the previous selling average. |
BSX - MULSTRXSSXIMETFP | SELL | -14,025 @ USD 104.12 | USD -1,460,283 | The ETF sold 14025 shares of BSX on 2025-06-24. The shares were previously bought for an average price of USD 99.2287. The MULSTRXSSXIMETFP shares were sold for 4.9% higher than average price of previous purchases. This sale made a profit of USD 68,600 The average price that the ETF previously sold BSX share for is USD 91.2952 so the ETF has sold 14025 shares on 2025-06-24 at a higher price than the previous selling average. |
ISRG - Intuitive Surgical Inc | SELL | -3,383 @ USD 523.08 | USD -1,769,580 | The ETF sold 3383 shares of ISRG on 2025-06-24. The shares were previously bought for an average price of USD 535.366. The Intuitive Surgical Inc shares were sold for -2.3% lower than average price of previous purchases. This resulted in an overall loss of USD 41,564 The average price that the ETF previously sold ISRG share for is USD 530.838 which is higher than the selling price of USD 523.08 on 2025-06-24. |
MRK - Marks Electrical Group PLC | SELL | -23,783 @ USD 80.32 | USD -1,910,251 | The ETF sold 23783 shares of MRK on 2025-06-24. The shares were previously bought for an average price of USD 90.2089. The Marks Electrical Group PLC shares were sold for -11.0% lower than average price of previous purchases. This resulted in an overall loss of USD 235,188 The average price that the ETF previously sold MRK share for is USD 97.0252 which is higher than the selling price of USD 80.32 on 2025-06-24. |
MRK - Merck & Company Inc | SELL | -23,783 @ USD 80.32 | USD -1,910,251 | The ETF sold 23783 shares of MRK on 2025-06-24. The shares were previously bought for an average price of USD 90.2089. The Merck & Company Inc shares were sold for -11.0% lower than average price of previous purchases. This resulted in an overall loss of USD 235,188 The average price that the ETF previously sold MRK share for is USD 97.0252 which is higher than the selling price of USD 80.32 on 2025-06-24. |
ABT - Abbott Laboratories | SELL | -16,490 @ USD 138.08 | USD -2,276,939 | The ETF sold 16490 shares of ABT on 2025-06-24. The shares were previously bought for an average price of USD 128.047. The Abbott Laboratories shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of USD 165,444 The average price that the ETF previously sold ABT share for is USD 118.919 so the ETF has sold 16490 shares on 2025-06-24 at a higher price than the previous selling average. |
UNH - UnitedHealth Group Incorporated | SELL | -8,568 @ USD 305.62 | USD -2,618,552 | The ETF sold 8568 shares of UNH on 2025-06-24. The shares were previously bought for an average price of USD 497.527. The UnitedHealth Group Incorporated shares were sold for -38.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,644,259 The average price that the ETF previously sold UNH share for is USD 530.028 which is higher than the selling price of USD 305.62 on 2025-06-24. |
ABBV - AbbVie Inc | SELL | -16,660 @ USD 185.55 | USD -3,091,263 | The ETF sold 16660 shares of ABBV on 2025-06-24. The shares were previously bought for an average price of USD 192.181. The AbbVie Inc shares were sold for -3.5% lower than average price of previous purchases. This resulted in an overall loss of USD 110,472 The average price that the ETF previously sold ABBV share for is USD 185.254 so the ETF has sold 16660 shares on 2025-06-24 at a higher price than the previous selling average. |
JNJ - Johnson & Johnson | SELL | -22,661 @ USD 152.19 | USD -3,448,778 | The ETF sold 22661 shares of JNJ on 2025-06-24. The shares were previously bought for an average price of USD 156.983. The Johnson & Johnson shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 108,614 The average price that the ETF previously sold JNJ share for is USD 152.718 which is higher than the selling price of USD 152.19 on 2025-06-24. |
LLY - Eli Lilly and Company | SELL | -7,361 @ USD 778.08 | USD -5,727,447 | The ETF sold 7361 shares of LLY on 2025-06-24. The shares were previously bought for an average price of USD 829.589. The Eli Lilly and Company shares were sold for -6.2% lower than average price of previous purchases. This resulted in an overall loss of USD 379,158 The average price that the ETF previously sold LLY share for is USD 793.329 which is higher than the selling price of USD 778.08 on 2025-06-24. |